MPI enables best in class cellular imaging to measure the efficacy of cancer immunotherapies.
Magnetic Insight (MI) introduced magnetic particle imaging into the preclinical diagnostic research market enabling quantitative cell tracking, imaging of vascular function, detecting metastatic tumors, visualizing inflammation, CAR-T cell therapies and initial research into regenerative medicine.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 23, 2022 | Series B | $17M | 1 | — | — | Detail |
Sep 1, 2020 | Grant | $1.60M | 1 | — | — | Detail |
Jun 1, 2019 | Grant | $1.80M | 1 | — | — | Detail |
Aug 1, 2018 | Grant | $1.50M | 1 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 21, 2019
Coindirect
|
Seed | €1.50M | Blockchain | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Gaingels | — | Series B |
National Institutes of Health | — | Grant |